Stay updated with breaking news from Professor Pascal Pujol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Joint study will assess clinical value of comprehensive genomic profiling (CGP) on cancer therapy options in patients with advanced disease
Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN), today announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University Hospital in France to...
/PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN), today announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University Hospital in France to...